Cointime

SuppreMol

company

About

SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.

  • 10001 - max

Highlights

Total Funding Amount
€40.70M $5.15M
Funding Rounds
4
Investors
2

Details

Last Funding Type
Series C
Last Funding Money Raised
€15.50M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2002
Number Of Employee
10001 - max
Operating Status
Active

SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
€40.70M $5.15M
SuppreMol has raised a total of €40.70M $5.15M in funding over 2 rounds. Their latest funding was raised on May 21, 2013 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 21, 2013 Series D €9.50M 1 — — Detail
Dec 17, 2010 Series C €15.50M 2 — — Detail
Jul 15, 2008 Series B €15.70M 1 — — Detail
May 24, 2006 Series A $5.15M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
SuppreMol is funded by 2 investors. FCP Biotech Holding and Bayern Kapital are the most recent investors.
Investor Name Lead Investor Funding Round
FCP Biotech Holding — Series D
Bayern Kapital — Series C
Cointime
เนื้อหา
บริษัท